BD is supporting and funding the development of the A4BC Forum and has commissioned Newmarket Strategy to provide secretariat and guidance. However, the objective of the Forum is to seek independent views and advice, ensuring an unbiased and inclusive platform is available for discussion and decision making.

BD (Becton Dickinson) is one of the largest medical technology companies in the world and has been at the forefront of healthcare safety and technology leadership for over 125 years, by improving medical discovery, diagnostics, and the delivery of care to help enhance outcomes, lower cost increase efficiencies, improve safety and expand access to healthcare. To learn more about Connected Medication Management visit BD